The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Hospital And Nursing Home Probiotics Market Expected To Change From 2026 To 2030?
The hospital and nursing home probiotics market has experienced rapid expansion in recent years. Its valuation is set to climb from $1.69 billion in 2025 to $1.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.4%. This historical growth can be attributed to several factors including increasing awareness of gut health benefits, greater antibiotic usage leading to digestive complications, the expanding elderly population in nursing homes, the broader application of clinical nutrition practices, and the rising accessibility of probiotic formulations.
The hospital and nursing home probiotics market size is projected to experience swift expansion over the coming years. By 2030, its size is anticipated to reach $2.86 billion, exhibiting a compound annual growth rate (CAGR) of 11.1%. This anticipated growth during the forecast period stems from factors such as an escalating emphasis on microbiome-centric health management, a surging requirement for immune system bolstering products, the increasing prevalence of digestive ailments, the broadening of preventive care initiatives within hospitals, and the expanded application of probiotics in extended care settings. Key trends foreseen for this period encompass the wider incorporation of probiotics into clinical nutrition plans, their increasing uptake for the care of elderly and immunocompromised individuals, their growing inclusion in preventive healthcare routines, the development of more condition-targeted probiotic formulas, and a rise in their acceptance as a complementary treatment in hospital environments.
Access Your Free Sample Report For In-Depth Market Analysis:
What Leading Drivers Are Supporting The Hospital And Nursing Home Probiotics Market Expansion?
The escalating occurrence of gastrointestinal disorders is projected to stimulate expansion within the hospital and nursing home probiotics market. These disorders encompass various conditions affecting the digestive tract, including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. The increasing incidence of such conditions stems from factors like unhealthy dietary habits, higher consumption of processed foods, sedentary lifestyles, and elevated stress levels. Hospital and nursing home probiotics play a crucial role in managing these disorders by restoring a healthy balance of gut bacteria, supporting digestive well-being, and mitigating symptoms such as diarrhea, constipation, and bloating. For instance, in December 2023, the IBD Registry, a UK-based non-profit organization, reported that by 2023, the number of individuals with Inflammatory Bowel Disease (IBD) exceeded 5,300, reflecting an increase of more than 3,000 members compared to 2022. Consequently, the rising prevalence of gastrointestinal disorders is a key driver for the growth of the hospital and nursing home probiotics market.
What Segment Categories Shape The Hospital And Nursing Home Probiotics Market Segment Landscape?
The hospital and nursing home probiotics market covered in this report is segmented –
1) By Indication: Antibiotic-Associated Diarrhea, Irritable Bowel Syndrome, Clostridium difficile Infection, Inflammatory Bowel Disease, General Gut Health
2) By Formulation Type: Capsules, Powder, Liquid
3) By Patient Group: Adults, Elderly, Immunocompromised Patients, Patients With Gastrointestinal Disorders
4) By Distribution Channel: Hospitals, Nursing Homes, Healthcare Facilities
5) By Application: Gut Health, Immunity
Subsegments:
1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD, Treatment of AAD
2) By Irritable Bowel Syndrome (IBS): IBS With Diarrhea (IBS-D), IBS With Constipation (IBS-C), Mixed IBS (IBS-M)
3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence, Treatment Of CDI
4) By Inflammatory Bowel Disease (IBD): Crohn’s Disease, Ulcerative Colitis
5) By General Gut Health: Immune System Support, Digestive Health, Gut Microbiome Restoration
What Emerging Trends Are Seen In The Hospital And Nursing Home Probiotics Market?
Companies operating significantly within the **hospital and nursing home probiotics market** are concentrating on developing innovative offerings, such as **probiotic solutions**, with the aim of enhancing patient gut health, improving recovery periods, and diminishing side effects linked to antibiotics. **Probiotic solutions** are products containing live microorganisms that confer health advantages when consumed in adequate quantities, typically by improving the balance of beneficial bacteria in the digestive system. For instance, in **October 2024**, **Probi AB**, a Sweden-based biotechnology firm specializing in probiotics, introduced **Metabolic Health by Probi** for use in healthcare environments. **Metabolic Health by Probi** is a clinically validated **probiotic solution** designed to support metabolic well-being, cardiovascular health, weight management, and blood pressure regulation by combining two proprietary probiotic strains, **Lactiplantibacillus plantarum 299v (LP299V)** and **Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2)**.
Who Are The Companies Operating Across The Hospital And Nursing Home Probiotics Market Value Chain?
Major companies operating in the hospital and nursing home probiotics market are Nestlé Health Science, Abbott Laboratories, Danone S.A., Yakult Honsha Co. Ltd., BioGaia AB, Lactalis Group, General Mills Inc., Arla Foods Group, Glanbia PLC, SymbioPharm GmbH, Klaire Labs, Procter & Gamble Company, Vitakem Nutraceuticals, Synlogic Inc., Bayer AG, Sanofi, Meiji Holdings Co. Ltd., Morinaga Milk Industry Co. Ltd., Otsuka Holdings Co. Ltd., Reckitt Benckiser Group plc
Get The Full Hospital And Nursing Home Probiotics Market Report:
Where Is The Hospital And Nursing Home Probiotics Market Most Concentrated Geographically?
North America was the largest region in the hospital and nursing home probiotics market in 2025. The regions covered in the hospital and nursing home probiotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hospital And Nursing Home Probiotics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Hospital And Nursing Home Probiotics Market 2026, By The Business Research Company
Probiotics Packaging Market Report 2026
https://www.thebusinessresearchcompany.com/report/probiotics-packaging-global-market-report
Probiotics Dietary Supplements Market Report 2026
Probiotics Food And Cosmetics Market Report 2026
https://www.thebusinessresearchcompany.com/report/probiotics-food-and-cosmetics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model